Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News
SYS-CON.TV
Cloud Expo & Virtualization 2009 East
PLATINUM SPONSORS:
IBM
Smarter Business Solutions Through Dynamic Infrastructure
IBM
Smarter Insights: How the CIO Becomes a Hero Again
Microsoft
Windows Azure
GOLD SPONSORS:
Appsense
Why VDI?
CA
Maximizing the Business Value of Virtualization in Enterprise and Cloud Computing Environments
ExactTarget
Messaging in the Cloud - Email, SMS and Voice
Freedom OSS
Stairway to the Cloud
Sun
Sun's Incubation Platform: Helping Startups Serve the Enterprise
POWER PANELS:
Cloud Computing & Enterprise IT: Cost & Operational Benefits
How and Why is a Flexible IT Infrastructure the Key To the Future?
Click For 2008 West
Event Webcasts
The 3rd NextGen China 2013 is Upcoming

- Seizing the business opportunity of generic drugs in the cycle of innovation & competition

SHANGHAI, Dec. 27, 2012 /PRNewswire/ -- After the great success of NextGen China 2012, CPhI Conferences is going to host the 3rd NextGen China 2013 on 28th-29th March in Shanghai. NextGen China 2013 will gather 120 plus key decision-makers from government agencies, generic and bio-pharma manufacturers for deeper discussions about the concerns and bottlenecks during the process of generics drug R&D, application, registration and production. Interactive topics will be diversified from 3 perspectives: regulatory updates, process quality innovation and "Going-out & Introducing-in" R&D cooperation. This is an indispensable industry insight and a networking platform tailor-made for domestic and overseas generic-pharma professionals, who contribute a lot to the generic drug value-chain growth and know-how upgrading.

(Photo: http://photos.prnewswire.com/prnh/20121227/CN34442)

March 2012 witnessed the first session of NextGen China 2012 in Shanghai. The conference has successively invited speakers from the FDA, USP, SIFDC and most leading pharmaceutical companies in both China and overseas, and 180 plus decision makers of generics development. Many attendees also had great comments on the event. Mr. Zhao Xiaowei, Project Manager of FERGUSON said, "The 2-day conference gave me a deeper understanding of China's generics technology dynamics and networking with many industrial professionals and peers." Mr. Zhang Suoqing, R&D Manager of North China Pharmaceutical said, "The conference gave me insight to generics impurity spectrum technical qualifications, the assessment of generics consistency, and USP Pharmacopoeia knowledge."

The emerging generics market is booming with the diversified opportunities and challenges:

  • Currently, the global generics market has a value of $80 billion and is growing at a rate of 8 percent, while the generic drug industry of China is growing at a tremendous rate of 25 percent
  • The next three to five years will see the peak period of patent expiry for international drugs, providing a good opportunity for most generics enterprises
  • China is a large market for generic drugs, constituting 95 percent of the Chinese drug market but their quality is far from satisfactory
  • China expects to become the world's second largest drug market in 2015

Above all, NextGen contributes to the extension of generic drugs, market expansion and technological updates for the generics manufacturers and innovative pharma manufacturers.

2013, Do you want to seize the opportunity of generic drugs in the cycle of innovation & competition?

  • Interpretation of the latest laws and policies concerning generic drugs - How can generic drugs make headway in their application of conforming to generic consistency?
  • The application process for generic drugs and the qualification requirements in assessing generic drugs - How to ensure that the production quality is up to standard and new achievements are made in innovation?
  • Ways of combining imitation with innovation for generic drugs - How can generic drugs match new technologies to maintain consistency?
  • New ideas of cooperation and R&D for generic drugs --- What to do next for the manufacture of generic drugs?

For more information, please log on www.nextgen-china.com or email to askconference@ubm.com

Media Contact

Ms. Tracy Cui
Tel: +86-21-6157-3919
Fax: +86-21-6157-7299
Email: tracy.cui@ubm.com

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Cloud Developer Stories
Compute virtualization has been transformational, yet security policy implementation and enforcement has lagged behind in agility and automation. There are a number of key considerations when implementing policy in private and hybrid clouds. In his session at 15th Cloud Expo, H...
SYS-CON Events announced today that SOA Software, an API management leader, will exhibit at SYS-CON's 15th International Cloud Expo®, which will take place on November 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA. SOA Software is a leading provider of API M...
How do APIs and IoT relate? The answer is not as simple as merely adding an API on top of a dumb device, but rather about understanding the architectural patterns for implementing an IoT fabric. There are typically two or three trends: Exposing the device to a management framewo...
SYS-CON Events announced today that Utimaco will exhibit at SYS-CON's 15th International Cloud Expo®, which will take place on November 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA. Utimaco is a leading manufacturer of hardware based security solutions that...
Samsung VP Jacopo Lenzi, who headed the company's recent SmartThings acquisition under the auspices of Samsung's Open Innovaction Center (OIC), answered a few questions we had about the deal. This interview was in conjunction with our interview with SmartThings CEO Alex Hawkinson...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021



SYS-CON Featured Whitepapers
ADS BY GOOGLE

Breaking Cloud Computing News

NEW YORK, Oct. 23, 2014 /PRNewswire/ -- This report analyzes the worldwide markets for Medical Tr...